Meribank Biotech Co (ROCO:4724) Net Issuance of Preferred Stock : NT$0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Meribank Biotech Co's net issuance of preferred for the six months ended in Dec. 2023 was NT$0.0 Mil. The number is 0, which means that Meribank Biotech Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Meribank Biotech Co's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.0 Mil.

Meribank Biotech Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Meribank Biotech Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Net Issuance of Preferred Stock Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial							-	-	-	-	-

Meribank Biotech Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

Meribank Biotech Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines